A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children - Trial NCT06305663
Access comprehensive clinical trial information for NCT06305663 through Pure Global AI's free database. This phase not specified trial is sponsored by Bausch & Lomb Incorporated and is currently Not yet recruiting. The study focuses on Myopia. Target enrollment is 418 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Bausch & Lomb Incorporated
Timeline & Enrollment
N/A
Mar 29, 2024
Jan 31, 2027
Primary Outcome
Mean change from baseline in axial length.,Mean change from baseline in cycloplegic SERE.
Summary
A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the
 Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06305663
Device Trial